Accurate Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.67M Buy
5,606
+376
+7% +$384K 0.64% 28
2026
Q1
$4.92M Sell
5,230
-107
-2% -$108K 0.59% 28
2025
Q4
$5.68M Buy
5,337
+157
+3% +$150K 0.72% 23
2025
Q3
$4.21M Buy
5,180
+608
+13% +$452K 0.56% 27
2025
Q2
$3.61M Buy
4,572
+299
+7% +$232K 0.55% 33
2025
Q1
$3.13M Buy
4,273
+93
+2% +$77.4K 0.6% 38
2024
Q4
$3.34M Buy
4,180
+114
+3% +$94.4K 0.64% 29
2024
Q3
$3.71M Buy
4,066
+1,071
+36% +$963K 0.75% 27
2024
Q2
$2.85M Buy
2,995
+250
+9% +$200K 0.68% 41
2024
Q1
$1.99M Sell
2,745
-93
-3% -$66.2K 0.58% 54
2023
Q4
$1.8M Sell
2,838
-166
-6% -$96.9K 0.56% 53
2023
Q3
$1.83M Buy
3,004
+398
+15% +$205K 0.57% 51
2023
Q2
$1.17M Buy
2,606
+337
+15% +$141K 0.37% 64
2023
Q1
$833K Sell
2,269
-22
-1% -$7.42K 0.29% 83
2022
Q4
$808K Sell
2,291
-459
-17% -$163K 0.3% 70
2022
Q3
$912K Buy
2,750
+1,583
+136% +$502K 0.38% 57
2022
Q2
$381K Sell
1,167
-55
-5% -$16.5K 0.21% 97
2022
Q1
$350K Buy
1,222
+133
+12% +$34.2K 0.16% 113
2021
Q4
$279K Buy
1,089
+62
+6% +$15.7K 0.23% 111
2021
Q3
$239K Buy
1,027
+29
+3% +$7.16K 0.21% 120
2021
Q2
$229K Buy
+998
New +$200K 0.2% 119

Other funds holding LLY

Accurate Wealth Management's LLY Position: Q2 2026 in Review

Accurate Wealth Management increased its Eli Lilly (LLY) stake by 7.2% in Q2 2026, buying an estimated $384K and bringing the position to 5,606 shares worth $6.67M. The position accounts for 0.64% of the portfolio, ranked #28.

Accurate Wealth Management first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. 1,691 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Accurate Wealth Management held 5,606 shares of Eli Lilly worth $6.67M as of Q2 2026.
  • Accurate Wealth Management bought 376 Eli Lilly shares in Q2 2026, an estimated $384K.
  • Eli Lilly made up 0.64% of Accurate Wealth Management's portfolio in Q2 2026, its #28 holding.
  • Accurate Wealth Management first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
  • 1,691 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Accurate Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.